Brain Energy Metabolism Changes and Neuropsychological Impairment in Parkinson Disease Vs Alzheimer Disease

Science Communicator Platform

Share By

Brain Energy Metabolism Changes and Neuropsychological Impairment in Parkinson Disease Vs Alzheimer Disease Publisher Pubmed

Khodadadi S ; Rezaeimanesh N ; Ariyae Motahar A ; Yousefi F ; Avateffazeli M ; Montazeri Shatouri R ; Hosseini E ; Sahab Negah S ; Naser Moghadasi A

Source: International Review of Neurobiology Published:2026

Abstract

Alzheimer’s disease (AD) and Parkinson’s disease (PD) are the most common neurodegenerative disorders, posing a significant public health risk. Although they are separate diseases, they have similar neuropsychological characteristics. Despite making up only a small portion of total body mass, the brain requires a disproportionately large amount of energy to maintain neuronal activity, synapse function, and cellular homeostasis. Disruption of energy metabolism is thus a major contributor to neurodegeneration. Energy metabolism has a wide-ranging impact on brain function, including cognitive and psychological processes, and gets increasingly compromised in neurodegenerative disorders. This chapter aims to offer a thorough overview of the link between altered brain energy metabolism and neuropsychological impairment in AD and PD. Copyright © 2026. Published by Elsevier Inc.

Related Docs

View other Related Docs

1. Iron Accumulation/Overload and Alzheimer's Disease Risk Factors in the Precuneus Region: A Comprehensive Narrative Review, Aging Medicine (2024)

2. Neutrophil to Lymphocyte Ratio in Parkinson’S Disease: A Systematic Review and Meta-Analysis, BMC Neurology (2023)

3. Diagnostic Performance of the Alzosure Predict Assay And Its Association With Alzheimer's Disease Biomarkers and Imaging Findings, Health Science Reports (2026)

Experts (# of related papers)

View all Related Experts

Ahmad Reza Khatoonabadi (1)

Seyed Morteza Karimian (1)

Other Related Docs

4. Differential Expression of Neurodegeneration-Related Genes in Sh-Sy5y Neuroblastoma Cells Under the Influence of Cyclophilin A: Could the Enzyme Be a Likely Trigger and Therapeutic Target for Alzheimer’S Disease?, Neurochemical Research (2025)

5. Therapeutic Potential of the Ketogenic Diet: A Metabolic Switch With Implications for Neurological Disorders, the Gut-Brain Axis, and Cardiovascular Diseases, Journal of Nutritional Biochemistry (2024)

6. Biology, Pathology, and Targeted Therapy of Exosomal Cargoes in Parkinson’S Disease: Advances and Challenges, Molecular Neurobiology (2025)

7. Neurodegenerative Diseases and Brain Delivery of Therapeutics: Bridging the Gap Using Dendrimers, Journal of Drug Delivery Science and Technology (2023)

8. Artificial Intelligence in Diagnosis and Prognosis of Cognitive Impairment in Parkinson’S Disease, Dementia and Geriatric Cognitive Disorders (2025)

9. Translation, Cultural Adaptation, and Validity of Barnes Language Assessment in Persian Ageing Population: A Preliminary Study, Journal of Modern Rehabilitation (2025)

10. Drift Diffusion Model of Animacy Categorization Task Can Detect Patients With Mild Cognitive Impairment and Mild Alzheimer's Disease, Frontiers in Biomedical Technologies (2021)

11. Design, Synthesis, Biological Evaluation, and Docking Study of Novel Dual-Acting Thiazole-Pyridiniums Inhibiting Acetylcholinesterase and Β-Amyloid Aggregation for Alzheimer's Disease, Bioorganic Chemistry (2020)

12. Morphine Addiction Is Tolerated Better in Socialized Male Rats, Sleep and Hypnosis (2018)

Style	Citing Format
MLA	Khodadadi S, et al.. "Brain Energy Metabolism Changes and Neuropsychological Impairment in Parkinson Disease Vs Alzheimer Disease." International Review of Neurobiology, vol. 188, no. , 2026, pp. 33-66.
APA	Khodadadi S, Rezaeimanesh N, Ariyae Motahar A, Yousefi F, Avateffazeli M, Montazeri Shatouri R, Hosseini E, Sahab Negah S, Naser Moghadasi A (2026). Brain Energy Metabolism Changes and Neuropsychological Impairment in Parkinson Disease Vs Alzheimer Disease. International Review of Neurobiology, 188(), 33-66.
Chicago	Khodadadi S, Rezaeimanesh N, Ariyae Motahar A, Yousefi F, Avateffazeli M, Montazeri Shatouri R, Hosseini E, Sahab Negah S, Naser Moghadasi A. "Brain Energy Metabolism Changes and Neuropsychological Impairment in Parkinson Disease Vs Alzheimer Disease." International Review of Neurobiology 188, no. (2026): 33-66.
Harvard	Khodadadi S et al. (2026) 'Brain Energy Metabolism Changes and Neuropsychological Impairment in Parkinson Disease Vs Alzheimer Disease', International Review of Neurobiology, 188(), pp. 33-66.
Vancouver	Khodadadi S, Rezaeimanesh N, Ariyae Motahar A, Yousefi F, Avateffazeli M, Montazeri Shatouri R, et al.. Brain Energy Metabolism Changes and Neuropsychological Impairment in Parkinson Disease Vs Alzheimer Disease. International Review of Neurobiology. 2026;188():33-66.
BibTex	@article{ author = {Khodadadi S and Rezaeimanesh N and Ariyae Motahar A and Yousefi F and Avateffazeli M and Montazeri Shatouri R and Hosseini E and Sahab Negah S and Naser Moghadasi A}, title = {Brain Energy Metabolism Changes and Neuropsychological Impairment in Parkinson Disease Vs Alzheimer Disease}, journal = {International Review of Neurobiology}, volume = {188}, number = {}, pages = {33-66}, year = {2026} }
RIS	TY - JOUR AU - Khodadadi S AU - Rezaeimanesh N AU - Ariyae Motahar A AU - Yousefi F AU - Avateffazeli M AU - Montazeri Shatouri R AU - Hosseini E AU - Sahab Negah S AU - Naser Moghadasi A TI - Brain Energy Metabolism Changes and Neuropsychological Impairment in Parkinson Disease Vs Alzheimer Disease JO - International Review of Neurobiology VL - 188 IS - SP - 33 EP - 66 PY - 2026 ER -

Science Communicator Platform

Authors

Abstract